Sekar Kathiresan
2020
In 2020, Sekar Kathiresan earned a total compensation of $2.4M as Chief Executive Officer at Verve Therapeutics.
Compensation breakdown
| Bonus | $230,400 |
|---|---|
| Option Awards | $1,687,500 |
| Salary | $480,000 |
| Other | $11,592 |
| Total | $2,409,492 |
Kathiresan received $1.7M in option awards, accounting for 70% of the total pay in 2020.
Kathiresan also received $230.4K in bonus, $480K in salary and $11.6K in other compensation.
Rankings
In 2020, Sekar Kathiresan's compensation ranked 4,725th out of 13,090 executives tracked by ExecPay. In other words, Kathiresan earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,725 out of 13,090 | 64th |
Division Manufacturing | 1,918 out of 5,621 | 66th |
Major group Chemicals And Allied Products | 751 out of 2,254 | 67th |
Industry group Drugs | 645 out of 1,954 | 67th |
Industry Pharmaceutical Preparations | 488 out of 1,459 | 67th |
Source: SEC filing on April 29, 2022.
Kathiresan's colleagues
We found one more compensation record of an executive who worked with Sekar Kathiresan at Verve Therapeutics in 2020.
2020
Andrew Bellinger
Verve Therapeutics